Related Experiment Video
Updated: Jun 18, 2025

07:15
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
Published on: August 16, 2020
6.8K
Early Detection of Pulmonary Embolism in a General Patient Population Immediately Upon Hospital Admission Using
Ori Ben Yehuda1, Edward Itelman2,3, Adva Vaisman2
1Department of Industrial Engineering and Management, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Journal of Medical Internet Research
|July 30, 2024
Summary
Machine learning models can now predict pulmonary embolism (PE) upon hospital admission using only medical records. This aids in early identification of high-risk patients before clinical evaluation, improving patient outcomes.
Area of Science:
- Medical Informatics
- Machine Learning in Healthcare
- Pulmonary Medicine
Background:
- Pulmonary embolism (PE) poses a significant threat due to challenges in timely identification.
- Late diagnosis of PE remains a critical issue in modern medicine.
Purpose of the Study:
- To develop accurate machine learning (ML) models for early identification of high-risk pulmonary embolism (PE) patients.
- To utilize only pre-admission medical record data for PE risk assessment.
Main Methods:
- A random forest ML algorithm was trained on demographics, comorbidities, and medications data.
- The study included 2568 PE patients and 52,598 controls, focusing on data available before emergency department admission.
- Specialized ML methods were employed to address data imbalance between PE and non-PE cases.
Main Results:
- Models predicted PE with 80% geometric mean accuracy using factors like age, BMI, past PE events, and anticoagulants.
- Clustering identified subgroups with over 61% PE prevalence, revealing associations with deep vein thrombosis and pneumonia.
- New risk factors, including previous pulmonary disease, were identified in general populations.
Conclusions:
- An ML tool enables early PE diagnosis upon hospital admission using historical medical data.
- The models accurately identified high-risk PE patients pre-clinically, even in imbalanced datasets.
- This approach allows for the discovery of novel PE risk factors beyond established scoring systems.

